CD9 anticorps

N° du produit ABIN135677

L’anticorps Souris Monoclonal anti-CD9 a été validé pour FACS. Il convient pour détecter CD9 dans des échantillons de Humain. Il y a 1 publication disponible.

Aperçu rapide pour CD9 anticorps (ABIN135677)

Antigène: CD9

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD9 est non-conjugé

Application: Flow Cytometry (FACS)

Clone: MM2-57

Détail du produit anti-CD9 anticorps

Specificité: Human/Hamster/Canine/Feline/Monkey/Rabbit/Raccoon CD9, Mr 24 kDa

Attributs du produit: Mouse Anti-Human CD9-UNLB

Purification: Purified

Immunogène: Unknown

Isotype: IgG2b

Information d'application

Indications d'application:

• Applications: FC - Quality tested , IHC-FS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature
• Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC and PE conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L

Commentaires:

platelet inhibition and aggregation studies

Volume d'échantillon: 1 mL

Restrictions: For Research Use only

Stockage

Concentration: 0.1 mg/mL

Buffer: 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

Agent conservateur: Without preservative

Conseil sur la manipulation: Each reagent is stable for the period shown on the bottle label if stored as directed.

Stock: 4 °C

Stockage commentaire: Store at 2-8°C

Références pour anticorps anti-CD9 (ABIN135677)

Kamisasanuki, Tokushige, Terasaki, Khai, Wang, Sakamoto, Kosai: "Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." dans: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).

Détails sur CD9

Antigène: CD9

Autre désignation: CD9

Sujet: CD9 is a 24 kDa member of the transmembrane 4 superfamily (TM4-SF) of cell surface receptors. It is expressed strongly on platelets, lymphoid progenitor cells, activated lymphocytes and endothelia, and, weakly, on eosinophils, granulocytes, monocytes, and macrophages. CD9 functions as an adhesion molecule where it mediates platelet aggregation and activation.

Pathways: Response to Water Deprivation, Cell-Cell Junction Organization